Loading...
Predicting treatment outcome in classical Hodgkin lymphoma: genomic advances
Classical Hodgkin lymphoma is considered a highly curable disease; however, 20% of patients cannot be cured with standard first-line chemotherapy and have a dismal outcome. Current clinical parameters do not allow accurate risk stratification, and personalized therapies are lacking. In fact, Hodgkin...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3129642/ https://ncbi.nlm.nih.gov/pubmed/21542892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/gm240 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|